Crescent Biopharma, Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Equivalents | $123.9M | $40.0M | $46.8M | $55.2M | $2.3M |
| Accounts Receivable | — | — | — | — | — |
| Inventory | — | — | — | — | — |
| Total Current Assets | $127.2M | $40.5M | $47.2M | $56.1M | $4.9M |
| Property, Plant & Equipment | $1.1M | $1.1M | $521.4K | $452.3K | $399.8K |
| Goodwill | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — |
| Total Assets | $128.6M | $42.4M | $48.5M | $57.3M | $5.3M |
| Liabilities | |||||
| Accounts Payable | $2.6M | $1.6M | $564.2K | $874.0K | $1.1M |
| Total Current Liabilities | $8.2M | $6.3M | $7.7M | $6.5M | $2.3M |
| Long-Term Debt | — | — | — | — | — |
| Total Liabilities | $8.9M | $7.1M | $8.0M | $6.5M | $2.4M |
| Stockholders' Equity | |||||
| Retained Earnings | $-152.3M | $-119.0M | $-87.2M | $-74.4M | $-63.3M |
| Total Stockholders' Equity | $119.7M | $35.3M | $40.5M | $50.8M | $2.9M |